Unknown

Dataset Information

0

A Small ?-Carboline Derivative "B-9-3" Modulates TGF-? Signaling Pathway Causing Tumor Regression in Vivo.


ABSTRACT: Targeting tumor microenvironment (TME) is crucial in order to overcome the anti-cancer therapy resistance. In this study, we report the antitumor activity of a newly synthesized ?-carboline derivative "B-9-3." Here, this small molecule showed a promising antitumor activity in vivo along with an enhanced immune response as reflected by a reduction of regulatory T cells and increased CD4+/CD8+ T cells. Further, B-9-3 decreased the number of myofibroblasts not only in the tumor but also in the lung suggesting an anti-metastatic action. The reduction of myofibroblasts was associated with lower expression of epithelial-to-mesenchymal transition markers and a decrease of phosphorylated SMAD2/3 complex indicating the implication of TGF-? signaling pathway in B-9-3's effect. The blockade of myofibroblasts induction by B-9-3 was also verified in vitro in human fibroblasts treated with TGF-?. To elucidate the mechanism of B-9-3's action on TGF-? pathway, first, we investigated the molecular interaction between B-9-3 and TGF-? receptors using docking method. Data showed a weak interaction of B-9-3 with the ATP-binding pocket of TGF?RI but a strong one with a ternary complex formed of extracellular domains of TGF?RI, TGF?RII, and TGF-?. In addition, the role of TGF?RI and TGF?RII in B-9-3's activity was explored in vitro. B-9-3 did not decrease any of the two receptors' protein level and only reduced phosphorylated SMAD2/3 suggesting that its effect was more probably due to its interaction with the ternary complex rather than decreasing the expression of TGF-? receptors or interfering with their ATP-binding domains. B-9-3 is a small active molecule which acts on the TGF-? signaling pathway and improves the TME to inhibit the proliferation and the metastasis of the tumor with the potential for clinical application.

SUBMITTER: Zhong H 

PROVIDER: S-EPMC6063040 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Small β-Carboline Derivative "B-9-3" Modulates TGF-β Signaling Pathway Causing Tumor Regression <i>in Vivo</i>.

Zhong Hui H   Daoud Abdelkader A   Han Jichun J   An Xiaohong X   Qiao Caili C   Duan Lanlan L   Wang Yichuan Y   Chen Zhenfeng Z   Zhou Jia J   Shang Jing J  

Frontiers in pharmacology 20180719


Targeting tumor microenvironment (TME) is crucial in order to overcome the anti-cancer therapy resistance. In this study, we report the antitumor activity of a newly synthesized β-carboline derivative "B-9-3." Here, this small molecule showed a promising antitumor activity <i>in vivo</i> along with an enhanced immune response as reflected by a reduction of regulatory T cells and increased CD4+/CD8+ T cells. Further, B-9-3 decreased the number of myofibroblasts not only in the tumor but also in t  ...[more]

Similar Datasets

| S-EPMC8373494 | biostudies-literature
| S-EPMC6072409 | biostudies-literature
| S-EPMC6681700 | biostudies-literature
| S-EPMC10140166 | biostudies-literature
| S-EPMC6372910 | biostudies-literature
| S-EPMC4598150 | biostudies-literature
| S-EPMC9508813 | biostudies-literature
| PRJEB9452 | ENA
| S-EPMC9366743 | biostudies-literature
| S-EPMC7730716 | biostudies-literature